Structure-activity relationship analysis of the peptide deformylase inhibitor 5-bromo-1H-indole-3-acetohydroxamic acid (Q43723745)

26 November 2017

Structure-activity relationship analysis of the peptide deformylase inhibitor 5-bromo-1H-indole-3-acetohydroxamic acid (English)

1 reference

26 November 2017

9

1 reference

26 November 2017

Carmela Giglione

4

0 references

author name string

Sylvain Petit

1

1 reference

26 November 2017

Yann Duroc

2

1 reference

26 November 2017

Valéry Larue

3

1 reference

26 November 2017

Carole Léon

5

1 reference

26 November 2017

Coralie Soulama

6

1 reference

26 November 2017

Alexis Denis

7

1 reference

26 November 2017

Frédéric Dardel

8

1 reference

26 November 2017

Isabelle Artaud

10

1 reference

26 November 2017

language of work or name

1 reference

1 February 2009

1 reference

26 November 2017

1 reference

26 November 2017

4

1 reference

26 November 2017

2

1 reference

26 November 2017

261-275

1 reference

Optimisation of a peptide library for screening specific RNA ligands by flow-injection NMR.

26 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

Characterization of the Thermus thermophilus locus encoding peptide deformylase and methionyl-tRNA(fMet) formyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Identification of eukaryotic peptide deformylases reveals universality of N-terminal protein processing mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Protein N-terminal methionine excision.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Characterization of a human peptide deformylase: implications for antibacterial drug design

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

An unusual peptide deformylase features in the human mitochondrial N-terminal methionine excision pathway

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

The crystal structure of mitochondrial (Type 1A) peptide deformylase provides clear guidelines for the design of inhibitors specific for the bacterial forms

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Peptide deformylase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Synthesis and PDF inhibitory activities of novel benzothiazolylidenehydroxamic acid derivatives

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Identification of novel potent bicyclic peptide deformylase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Arylboronic acids and arylpinacolboronate esters in Suzuki coupling reactions involving indoles. Partner role swapping and heterocycle protection

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Synthesis and quantitative structure-activity relationships of diclofenac analogues

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Orally active aldose reductase inhibitors: indazoleacetic, oxopyridazineacetic, and oxopyridopyridazineacetic acid derivatives

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Selective thromboxane synthetase inhibitors. 2. 3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indole-1-propanoic acid and analogues

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

2,3-Substituted 2-azanorbornanes as polar β-turn mimetics

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

New selective nonsteroidal aromatase inhibitors: synthesis and inhibitory activity of 2,3 or 5-(alpha-azolylbenzyl)-1H-indoles

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

A general method for acylation of indoles at the 3-position with acyl chlorides in the presence of dialkylaluminum chloride

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Perspectives on NMR in drug discovery: a technique comes of age

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Cation-pi interactions involving aromatic amino acids

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Control of peptide deformylase activity by metal cations.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Formate dehydrogenase-coupled spectrophotometric assay of peptide deformylase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

A new subclass of the zinc metalloproteases superfamily revealed by the solution structure of peptide deformylase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Solution structure of nickel-peptide deformylase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Design and Synthesis of Substrate Analogue Inhibitors of Peptide Deformylase†

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

NMR-Guided Fragment-Based Approach for the Design of tRNALys3 Ligands

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

NMRPipe: a multidimensional spectral processing system based on UNIX pipes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800251

7 January 2021

Identifiers

DOI

10.1002/CMDC.200800251

1 reference

26 November 2017

1 reference